arrow
M

Marta García de Herreros

University of Barcelona
H指数:11
被引数:505

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Non-Cancer Causes of Death in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Analysis

转移性激素敏感性前列腺癌患者的非癌性死亡原因:一项真实世界分析

2026-05-010
OAAI
Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry

肺癌与其他肿瘤的静脉血栓栓塞比较:TESEO-SEOM登记研究的结果

2025-11-030
PRE
Multidrug resistance and recurrence in urinary bacteraemia among cancer patients

肿瘤患者尿路细菌血症中的多药耐药性与复发

2025-09-010
PRE
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)

驱动基因致癌突变在非小细胞肺癌中的频率及欧洲室内氡暴露的估计(RADON EUROPE研究)

2025-06-260
OA
Corrigendum to “Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors” [Eur. Urol. Open Sci. 70 (2024) 86–90]

勘误:“接受雄激素受体通路抑制剂治疗的有转移性激素敏感性前列腺癌患者中RB1、PTEN和TP53基因的预后表达特征”[Eur. Urol. Open Sci. 70 (2024) 86–90]

2025-06-040
OA
Corrigendum to “Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients” [Eur. Urol. Oncol. 7 (2024) 954–964]

勘误:关于“基于RB1、PTEN和TP53在转移性激素敏感性前列腺癌患者中开发并独立验证预后基因表达签名”[Eur. Urol. Oncol. 7 (2024) 954–964]

2025-05-010
PRE
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)

简报:循环肿瘤DNA下一代测序在晚期肺鳞癌患者中的临床实用性(SQUIN)

2025-02-140
PRE
Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors

雄激素受体途径抑制剂治疗的转移性激素敏感型前列腺癌患者RB1、PTEN和TP53基因的预后表达特征

2024-12-011
PRE
Indoor radon in patients with lung cancer in Spain: Preliminary data from the MIRROR study

西班牙肺癌患者室内氡水平:MIRROR研究的初步数据

2024-09-010
PRE
Cancer mortality in young population and estimated radon areas in Spain

西班牙年轻人群癌症死亡率与估计氡暴露地区

2024-09-010
PRE
Tumour suppressor gene signature predicts early progression in metastatic hormone-sensitive metastatic prostate cancer (mHSPC) patients

肿瘤抑制基因特征可预测转移性激素敏感性前列腺癌(mHSPC)患者的早期进展

2024-09-010
PRE
Prediction of clinically significant bleeding in anticoagulated patients for cancer-associated venous thromboembolism: Validation of B-CAT score in a cohort from the TESEO study

癌症相关静脉血栓栓塞症抗凝患者的临床显著出血预测:TESEO研究中B-CAT评分在队列中的验证

2024-09-010
PRE
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
2024-08-014
OA
Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment
2024-03-293
OAAI
Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients

肿瘤患者胆源性血流感染复发的流行病学和危险因素

2023-10-172
OAAI
Molecular profiling and prognostic relevance of low PTEN expression in metastatic hormone-sensitive prostate cancer patients
2023-10-010
PRE
Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
2023-10-010
OA